An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma
Clinical trial NCT00563056 · COMPLETED
Trial details
- NCT number
- NCT00563056
- Sponsor
- Mundipharma Research Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-04-01
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.